Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2001, p. 3913-3925, Vol. 21, No. 12
Dipartimento di Biotecnologie e Bioscienze,
Università degli Studi di Milano-Bicocca, 20126 Milan, Italy
Received 13 November 2000/Returned for modification 16 March
2001/Accepted 28 March 2001
DNA damage checkpoints lead to the inhibition of cell cycle
progression following DNA damage. The Saccharomyces
cerevisiae Mec1 checkpoint protein, a phosphatidylinositol
kinase-related protein, is required for transient cell cycle arrest in
response to DNA damage or DNA replication defects. We show that
mec1 kinase-deficient (mec1kd) mutants
are indistinguishable from mec1
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.12.3913-3925.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of mec1
Kinase-Deficient Mutants and of New Hypomorphic mec1
Alleles Impairing Subsets of the DNA Damage Response Pathway
cells, indicating that the Mec1 conserved kinase domain is required for all known Mec1
functions, including cell viability and proper DNA damage response.
Mec1kd variants maintain the ability to physically interact with both
Ddc2 and wild-type Mec1 and cause dominant checkpoint defects when
overproduced in MEC1 cells, impairing the ability of
cells to slow down S phase entry and progression after DNA damage in
G1 or during S phase. Conversely, an excess of Mec1kd in
MEC1 cells does not abrogate the G2/M
checkpoint, suggesting that Mec1 functions required for response to
aberrant DNA structures during specific cell cycle stages can be
separable. In agreement with this hypothesis, we describe two new
hypomorphic mec1 mutants that are completely defective
in the G1/S and intra-S DNA damage checkpoints but properly
delay nuclear division after UV irradiation in G2.
The finding that these mutants, although indistinguishable from
mec1
cells with respect to the ability to replicate a
damaged DNA template, do not lose viability after UV light and methyl methanesulfonate treatment suggests that checkpoint impairments do not
necessarily result in hypersensitivity to DNA-damaging agents.
*
Corresponding author. Mailing address: Dipartimento di
Biotecnologie e Bioscienze, Università degli Studi di
Milano-Bicocca, Piazza della Scienza 2, 20126 Milan, Italy. Phone:
39-02-64483425. Fax: 39-02-64483565. E-mail:
mariapia.longhese{at}unimib.it.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|